BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ENTrigue Surgical, Inc. Announces Product Commercialization


9/18/2008 10:51:11 AM

SAN ANTONIO, Sept. 18 /PRNewswire/ -- ENTrigue Surgical, Inc. announces the commercial release of its initial SerpENT(TM) Articulating Instruments, the first of several innovative solutions for ENT (Ear, Nose, and Throat) surgery. The SerpENT(TM) instruments utilize a patented technology that enables instruments to bend around corners, resulting in less invasive and more efficient surgical procedures. The Company plans to commercialize several additional unique solutions for ENT procedures, including products based on absorbable polymer technologies. Fred Dinger, President and CEO of ENTrigue Surgical commented, "We believe that by listening to the surgeons in the field, we can identify opportunities for innovation in Otolaryngology. We are developing novel and practical products that simplify procedures for surgeons and improve healing for patients." ENTrigue will showcase its products and technologies in booth # 589 at the AAO-HNS/F Annual Meeting & OTO EXPO in Chicago, IL from September 21-24, 2008.

Since its inception in May 2007, ENTrigue Surgical has built a robust intellectual property portfolio with several patents issued, pending and licensed around its core technologies. The Company has also established collaborative partnerships with biomaterials innovators, such as Tepha, Inc., as well as with developers and manufacturers of unique surgical instrumentation. ENTrigue Surgical recently completed a $6.4 million Series B financing to further develop and commercialize its ground-breaking technologies. Existing shareholders and principal healthcare investors, The Vertical Group and Prism VentureWorks, led the financing.

About ENTrigue Surgical, Inc.

ENTrigue Surgical is a privately held medical device company formed with the objective of innovating and delivering next generation devices and therapies for the ENT operating room and office. Products from ENTrigue Surgical focus on enhancing surgical access for increased functionality and precision. Unique to the industry, ENTrigue Surgical is also developing a new class of clinically proven bioabsorbable and biologic implants designed to simplify surgical procedures and improve healing.

For further information on ENTrigue Surgical and its technologies, please visit http://www.entriguesurgical.com or contact:

CONTACT: Prasad Nalluri of ENTrigue Surgical, Inc., +1-210-298-6332

Web site: http://www.entriguesurgical.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES